Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...

Get Instant Summarized Text (Gist) Lipid nanoparticles encapsulating mRNA have been successfully delivered to the intestines, bypassing the liver, by altering the lipid composition. This method ...

A new class of lipids improve the rates at which lipid nanoparticles (LNPs) successfully deliver RNA therapeutics and gene editing tools, promising to increase their effectiveness of such treatments.

This groundbreaking development may enable treatments for inflammatory diseases such as Crohn's and colitis. Researchers at Tel Aviv University have achieved a major breakthrough in drug delivery ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking system and its counterpart on the station.

A similar challenge arises at the microscopic level when lipid nanoparticles (LNPs) — the revolutionary drug delivery vehicles behind the COVID-19 vaccines — attempt to deliver mRNA to cells.

Genetic medicines could treat certain diseases, however, the current delivery systems available—viral vectors and lipid nanoparticles (LNPs)—pose unique challenges for gene therapy applications. For ...